What Happened?
Beltsville, MD-based NextCure Appointed Michael Richman as Chairman and Chief Executive Officer
About the Company
NextCure is a fully integrated biotechnology company discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases. The company is focused on understanding biological pathways and leveraging our FIND-IOTM technology to discover, validate and build a proprietary pipeline. We believe identifying and targeting immune pathways will promote identification of effective targets for mediating sustained immunity leading to improved outcomes for cancer patients.
About the Person
Michael Richman is Chairman and Chief Executive Officer at NextCure. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile